ARHGEF2 and familial pancreatic carcinoma: These results reveal an essential role for SP3 in transactivation of the ARHGEF2 promoter downstream of oncogenic KRAS and modulation of invasion-migration and anchorage independent growth of pancreatic cancer cells.